ArticleApplied biochemistry and biotechnology2026
Biofunctionalization of Selenium Nanoparticles with Moringa Oleifera Modulates Redox Balance and Inflammatory Responses in Experimental Hyperglycemia.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus is associated with sustained oxidative stress and inflammation that drive progressive cellular and tissue dysfunction. Selenium is a key redox-regulating trace element; however, how phytochemical surface functionalization alters the biological performance of selenium-based nanomaterials remains insufficiently defined. This study comparatively evaluated selenium nanoparticles (SeNPs), Moringa oleifera-derived nanoparticles (MONPs), and M. oleifera-functionalized selenium nanoparticles (MO-SeNPs) in a streptozotocin-induced diabetic rat model. Diabetes induction resulted in hyperglycemia, elevated glycated hemoglobin (HbA1c), increased lipid peroxidation, enhanced pancreatic TNF-α levels, impaired antioxidant defenses, and marked pancreatic, hepatic, and renal tissue injury. All nanoformulations partially improved these parameters; however, MO-SeNPs produced the most consistent improvement in long-term glycemic control (HbA1c), redox balance, inflammatory markers, and tissue architecture. Notably, selenium-based nanomaterials exhibited context-dependent redox effects in non-diabetic animals, underscoring the importance of dose and disease state. Collectively, these findings demonstrate that phytochemical functionalization modulates the applied biochemical performance of selenium nanoparticles and supports biofunctionalization as an optimization strategy for redox-targeted nanomaterials.
Indexed as
Identifiers
42455217What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.